Only under extreme conditions can anything be tested. Jessie Evans and her team at Journal of Biomedical Research and Environmental Sciences faced such a challenge when presented with an article about how to die. Normally, a medical journal expects articles about how to save lives and prevent suffering. Here was a Professor of Advanced Medicine explaining how to die. Was he crazy? Fortunately, they saw that this was a deliberate provocation. It was a way to get readers to think about the dangers to health.
Jessie’s team read the article, understood the author’s intent and quickly got it published without any changes. They were up to the challenge of an innovative author.
Andrew Hague
Professor of Advanced Medicine
President of CellSonic Limited
Other Topics
Some supper friendly can be used as section subtitle
Research Article 2020-12-16
Sampling and Characterization of the Environmental Fungi in the Provincial Historic Archive of Pinar Del RÃo, Cuba
Letter to Editor 2020-11-18
Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections
Review Article 2020-11-12
Sex and Age Differences in Telomere Length and Susceptibility to COVID-19
Research Article 2020-10-26
In silico Screening of Approved Drugs to Describe Novel E. coli DNA Gyrase A Antagonists
Review Article 2020-10-14
Remdesivir Research Progress: An Overview of the Emerging Evidence
Review Article 2020-09-28
Biophysical Aspects of Interactions at the Bionanointerface between Viruses and Metal and Metal Oxide Nanomaterials
Research Article 2020-09-10
Primary Prevention of New Pandemic and Biomimetic-Based Adaptation to Situation Connected with COVID-19 Pandemic
Review Article 2020-08-13
A Review: Artemisinin-Based Combination Therapies [ACTs] and K13 Polymorphism
Review Article 2020-08-12
Covid-19 Pandemic-Insights and Challenges
Short Communication 2020-07-02
The Hypothetical Role of Erythrocytes in COVID-19: Immediate Clinical Therapy
Research Article 2020-06-17
Determination of an Antiviral Activity of a Composition Comprising Glutathione Reductase (GSSG-R) and Oxidized Glutathione (GSSG) for Pharmaceutical use: Experiments In vitro and In vivo